Medicines A-Z
Back to Trajenta Tablet (Linagliptin)

Trajenta (Linagliptin) Uses in Pakistan

Trajenta (Linagliptin) is a widely used DPP-4 inhibitor for Type 2 Diabetes in Pakistan. All approved uses, patient profiles, and contraindications are covered in this guide.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Uses

Quick Answer

Trajenta (Linagliptin 5mg) is used to treat Type 2 Diabetes Mellitus in adults. It can be used alone or combined with Metformin, sulfonylureas, or insulin. A key advantage: no dose adjustment needed in renal impairment. Always take as prescribed by your doctor.

Primary Uses at a Glance

Type 2 Diabetes Mellitus — Monotherapy

Trajenta (Linagliptin) is used as monotherapy in adults with Type 2 Diabetes whose blood sugar is not controlled by diet and exercise alone, especially when Metformin is not tolerated or contraindicated.

As prescribed by your doctor. Standard adult dose: 5mg once daily.

Type 2 Diabetes — Add-on Combination Therapy

Linagliptin is commonly added to existing diabetes regimens including Metformin, sulfonylureas (SU), or basal insulin when additional blood sugar lowering is needed.

As prescribed by your doctor. Standard adult dose: 5mg once daily.

Type 2 Diabetes with Renal Impairment

Unlike most other DPP-4 inhibitors (Sitagliptin, Saxagliptin) that require dose reduction in kidney disease, Linagliptin does NOT need dose adjustment in renal impairment — it is excreted mainly via bile/faeces, making it a preferred gliptin in CKD patients.

As prescribed by your doctor. Standard adult dose: 5mg once daily — unchanged regardless of kidney function.

Other Uses

  • Elderly patients with Type 2 Diabetes requiring a well-tolerated once-daily agent
  • Patients on hemodialysis or with stage 3-5 CKD needing a gliptin

Trajenta (Linagliptin) Uses (Fayde / Kis kaam aati hai)

Trajenta contains Linagliptin and belongs to the DPP-4 Inhibitor (Gliptin) group. Below are all the approved and common uses of Trajenta in Pakistan.

Primary Uses (Mukhya Istemal)

  • Type 2 Diabetes Mellitus — monotherapy (akele use)
  • Type 2 Diabetes — combination therapy with Metformin, SU, or insulin
  • Type 2 Diabetes with renal impairment — no dose adjustment needed

Who Should Take It (Kin logon ke liye)

  • Adults with Type 2 Diabetes not controlled with diet and exercise alone
  • Patients who cannot tolerate Metformin
  • CKD patients who need a gliptin — Linagliptin preferred due to renal-safe profile
  • Adults needing a once-daily, glucose-dependent sugar-lowering agent

When NOT to Use Trajenta (Kab nahi leni chahiye)

  • If you are allergic to Linagliptin or any of its ingredients
  • In Type 1 Diabetes Mellitus
  • In diabetic ketoacidosis (DKA)
  • During pregnancy or breastfeeding without medical advice

Summary

Trajenta is prescribed for Type 2 Diabetes Mellitus — alone or in combination. Its renal-safe profile makes it particularly valuable in patients with kidney disease. Always use with a doctor's prescription.

The information in this guide is for educational purposes only.

Frequently Asked Questions

Trajenta kin conditions mein sabse zyada effective hai?

Trajenta (Linagliptin) is effective for blood sugar control in Type 2 Diabetes — both as monotherapy and in combination. It is particularly preferred in patients with kidney disease because no dose adjustment is needed.

Kya Trajenta doctor ke bina le sakte hain?

No — Trajenta is a prescription (Rx) medicine. Do not take it without a doctor's advice. It has some serious side effects (pancreatitis, skin blistering) that can be missed without monitoring.

Trajenta kab tak results dikhata hai?

Improvement in blood sugar may be visible within 1–2 weeks, but the full HbA1c benefit is assessed at 3 months. Follow regular monitoring as directed by your doctor.

Kya Trajenta lambe arse tak le sakte hain?

Long-term use is safe under doctor supervision. Regular HbA1c, blood pressure, and renal function tests are required. Do not stop on your own.

Agar Trajenta kaam na kare to kya karein?

If blood sugar is not controlled, do not increase the dose on your own — see your diabetologist. Combination therapy or an alternative agent may be needed.

Related medicines

Brand alternatives, same-class options, and other medicines used for the same conditions as Trajenta Tablet (Linagliptin).

Other diabetes medicines

Sibling medicines in the Diabetes Medicines class.

All in class →

Used for the same conditions

Other medicines commonly used for diabetes and overlapping conditions.

Diabetes hub →

Sources

  1. DRAP Registered Products Database — Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
  3. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.